/C O R R E C T I O N -- IsoTis OrthoBiologics/
30 Januar 2007 - 8:56AM
PR Newswire (US)
In the news release, IsoTis, Inc. Files Registration Statement for
Public Offering, issued yesterday by IsoTis OrthoBiologics over PR
Newswire, the dateline city should read "IRVINE, Calif." rather
than "IRVINE, Canada" as incorrectly transmitted by PR Newswire.
Complete, corrected release follows: IRVINE, Calif., January 29
/PRNewswire-FirstCall/ -- IsoTis, Inc. (NASDAQ: ISOT), the
orthobiologics company, announced today that it has filed a Form S-
1 registration statement with the Securities and Exchange
Commission for a proposed public offering of its common stock. The
lead underwriter for the offering is Thomas Weisel Partners LLC.
William Blair & Company is acting as co-manager. The offering
will be made only by means of a prospectus. When available, copies
of the preliminary prospectus relating to this offering may be
obtained from Thomas Weisel Partners, at One Montgomery Street,
Suite 3700, San Francisco, CA 94104, Tel: +1-415-364-2720. A
registration statement relating to these securities has been filed
with the Securities and Exchange Commission but has not yet become
effective. These securities may not be sold nor may offers to buy
be accepted prior to the time that the registration statement
becomes effective. This press release shall not constitute an offer
to sell or the solicitation of an offer to buy nor shall there be
any sale of these securities in any state or jurisdiction in which
such offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of any such
state. Certain statements in this press release are
"forward-looking statements" within the meaning of Section 21E of
the Securities Exchange Act of 1934, as amended, including those
that refer to management's plans and expectations for future
operations, prospects and financial condition. Words such as
"strategy," "expects," "plans," "anticipates," "believes," "will,"
"continues," "estimates," "intends," "projects," "goals,"
"targets," "could," 'may," and other words of similar meaning are
intended to identify such forward-looking statements. One can also
identify them by the fact that they do not relate strictly to
historical or current facts. Such statements are based on the
current expectations of the management of IsoTis, Inc. only. Undue
reliance should not be placed on these statements because, by their
nature, they are subject to known and unknown risks and can be
affected by factors that are beyond the control of IsoTis, Inc.
Actual results could differ materially from current expectations
due to a number of factors and uncertainties affecting IsoTis,
Inc., including, but not limited to, failure to obtain sufficient
shareholder support for the exchange offer, inability to list the
IsoTis, Inc. shares on NASDAQ in a timely manner, if at all, market
conditions at the time of the proposed offering and inability to
obtain approval from the SEC for the offering. IsoTis, Inc.
expressly disclaims any intent or obligation to update these
forward-looking statements except as required by law. DATASOURCE:
IsoTis OrthoBiologics
Copyright